InvestorsHub Logo

Carboat

10/06/15 6:07 AM

#237828 RE: tradero #237827

Not at all. Here you go, no mention of the stellar shareprice.

Enough to give validity to "Bavi also works for humans". The preclinical trials were ovewhelming positive. Rats were not just only cured but developped a self induced anti-cancer system


Yes validity but not proof. Rats and preclinical often different result that large trial like SUnrise

Bavi would boost results for ALL "competition" known so far. Current competition would love to have a Bavi combo.


Maybe, but again no proof bavi will boost "ALL competition". No bidders so far others than the one that ran away after the botched trial and no terms of that deal known.

I trust management when they say "Enrollment is on track"... That is NOT vague to me.


It is by definition vague when you know the enrollment is not linear and there was a ramp (hockey stick) for sites. Still time for pphm to say they need to extend the enrollment and still be technically "on-track" is the point.

600 patients are a pretty big number for such an anomaly to happen


Agree on that one it would seem unlikely ... but pphm seems to be a magnet for the unlikely

Carboat

10/06/15 6:29 AM

#237829 RE: tradero #237827

I do think you have hit on something here though.

You see, my money is where my beliefs are...

Perhaps it is the other way around for many pphm investors. Their beliefs are where their money is. I don't subscribe to the idea that if you are long you must only heap praise on your investment and ignore any pphm issues. I just tell them like I see them regardless of my investment position.